查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1577508

心臟病診斷的全球市場

Heart Attack Diagnostics
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 179 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

到 2030 年，全球心臟病診斷市場將達到 198 億美元

全球心臟病診斷市場預計 2023 年為 137 億美元，預計到 2030 年將達到 198 億美元，2023-2030 年分析期間複合年成長率為 5.5%。醫院最終用途是本報告分析的細分市場之一，預計複合年成長率為 6.1%，到分析期結束時將達到 98 億美元。在分析期間，診斷中心最終用途細分市場的複合年成長率預計為 5.1%。

美國市場預估成長37億美元，中國複合年成長率為9.0%

預計 2023 年美國心臟病診斷市場規模將達 37 億美元。中國作為世界第二大經濟體，預計2030年市場規模將達42億美元，2023-2030年分析期間複合年成長率為9.0%。其他值得注意的區域市場包括日本和加拿大，在分析期間預計複合年成長率分別為 2.2% 和 5.6%。在歐洲，德國的複合年成長率預計為 3.4%。

全球心臟病診斷市場—主要趨勢和促進因素總結

為什麼心臟科診斷能夠改變心血管治療的遊戲規則？

心臟病發作診斷是現代心血管護理的基石，為早期準確檢測心肌梗塞 (MI) 提供了重要工具，可以極大地改變患者的治療結果。但到底是什麼讓這些診斷如此有影響力，為什麼它們在醫療保健中扮演越來越重要的角色？當阻塞限制血液流向心臟，導致組織損傷時，就會發生心臟疾病。及時診斷至關重要，因為溶栓治療和經皮冠狀動脈介入治療 (PCI) 等救生治療的有效性取決於早期發現。 「黃金時間」的概念——症狀出現後的關鍵時限——使得臨床醫生必須獲得可靠、快速的診斷工具來指南治療決策。診斷影像技術來確定心臟問題的存在和嚴重程度，這些工具的速度和準確性決定了患者是否及時接受適當的治療，因為這是心臟病診斷中持續技術創新的必要性。地減少長期併發症這些技術在急診醫學和常規臨床實踐中已變得至關重要。

塑造心臟病診斷市場的新興趨勢是什麼？

心臟病診斷市場正在經歷尖端創新和臨床實踐轉變的變革時期，旨在改善患者的治療結果。最重要的發展之一是高靈敏度心肌肌鈣蛋白 (hs-cTn) 檢測的日益普及。這種敏感性的提高可以更早、更準確地檢測到心臟病發作，從而縮短治療時間並提高預後準確性，特別是對於症狀不典型的患者。另一個主要趨勢是 POCT（即時檢測）設備的廣泛使用。 POCT 設備可以在床邊甚至在救護車等院前環境中進行快速診斷。這些可攜式設備可以在幾分鐘內提供結果，支援更快的分類並減少對集中實驗室測試的依賴，從而正在改變急診醫學。此外，人工智慧（AI）和機器學習在診斷平台中的整合正在徹底改變複雜資料（例如心電圖模式和成像結果）的解釋，有助於檢測人類臨床醫生可能忽略的微妙跡象，從而帶來發現。此外，結合了多種生物標記物（例如利尿鈉胜肽和發炎標記物）的多標記物組合也越來越受到關注，因為它們提供了更細緻的心臟健康狀況，並有助於區分心臟病和其他心臟病。總而言之，這些趨勢使得心臟病診斷變得更快、更準確，並且越來越個人化，反映出心血管治療中向精準醫療的轉變。

新技術如何重新定義心臟病診斷？

科技的突破正在再形成心臟病診斷的格局，使工具比以往任何時候都更有效率、更容易使用、更準確。最有影響力的進步之一是診斷設備的小型化，創建了可攜式手持系統，即使在遠端或資源有限的環境中，也可以快速提供靠近患者的測試結果。這些設備，包括現場心臟生物標記分析儀和可攜式心電圖監測儀，無需複雜的實驗室設置即可實現即時診斷和治療決策，從而改變緊急護理。穿戴式科技是該領域的另一場革命，智慧型手錶和健康手環現在可以持續監測心臟活動，並即時提醒使用者和醫療保健提供者可能的心臟病發作症狀。此功能對於高風險患者特別有價值，因為它可以對潛在的心臟事件進行主動管理和快速反應。此外，人工智慧 (AI) 可以快速且準確地解讀複雜的心臟資料，從而增強超音波心動圖、 電腦斷層掃描和 MRI 等診斷影像的能力。人工智慧主導的平台可以偵測人眼可能錯過的微妙模式和異常，從而實現更快、更可靠的診斷。此外，雲端基礎的平台和遠端醫療整合實現了遠距離診斷，使臨床醫生可以更輕鬆地從幾乎任何地方存取和解釋測試結果。這些創新不僅提高了心臟病診斷的準確性和可近性，而且徹底改變了心血管護理的提供方式，為更主動、資料主導的患者管理方法鋪平了道路。

心臟病診斷市場快速成長的關鍵促進因素是什麼？

心臟病診斷市場的成長主要受到多種因素的推動，例如技術進步、心血管疾病負擔的增加以及快速且易於使用的診斷解決方案的轉變。主要成長要素之一是心血管疾病的全球增加，心血管疾病仍然是全球死亡的主要原因。人口老化，加上肥胖、高血壓和糖尿病等與生活方式相關的危險因子日益普遍，顯著增加了需要可靠診斷工具的患者群體。此外，人們對早期檢測和預防重要性的認知不斷提高，推動了對先進生物標記檢測和非侵入性成像技術的需求，這些技術可以在最早階段識別心臟病發作。另一個關鍵促進因素是就地檢驗(POCT) 設備的日益普及。 POCT 設備在緊急情況、門診診所甚至居家醫療環境中提供快速診斷功能。這些可攜式設備滿足了快速診斷和開始治療的需求，減少了醫院實驗室的壓力，並提高了繁忙的急診室的患者吞吐量。人工智慧驅動的診斷平台和高靈敏度生物標記測試等技術創新透過提高診斷準確性和實現個人化風險評估，進一步推動市場成長。此外，遠端醫療和遠端監控解決方案的使用正在增加，擴大了心臟病診斷的範圍，特別是在傳統醫療保健設施有限的農村和服務不足的地區。有利的法律規範和報銷政策也鼓勵新診斷技術的開發和採用，從而惠及更廣泛的患者群體。這些因素加上對研發的持續投資，正在推動市場格局向前發展，並將其確立為不斷發展的循環系統治療的關鍵組成部分。

受訪企業範例（總合35 家）

  • Abbott Laboratories, Inc.
  • ACS Diagnostics
  • Baxter International, Inc.
  • Beckman Coulter, Inc.
  • Canon Medical Systems USA, Inc.
  • F. Hoffmann-La Roche AG
  • GE Healthcare
  • HeartBeam
  • Midmark Corporation
  • Philips Healthcare

目錄

第1章調查方法

第 2 章執行摘要

  • 市場概況
  • 主要企業
  • 市場趨勢和促進因素
  • 全球市場展望

第3章市場分析

  • 美國
  • 加拿大
  • 日本
  • 中國
  • 歐洲
  • 法國
  • 德國
  • 義大利
  • 英國
  • 西班牙
  • 俄羅斯
  • 其他歐洲國家
  • 亞太地區
  • 澳洲
  • 印度
  • 韓國
  • 其他亞太地區
  • 拉丁美洲
  • 阿根廷
  • 巴西
  • 墨西哥
  • 其他拉丁美洲
  • 中東
  • 伊朗
  • 以色列
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國
  • 其他中東地區
  • 非洲

第4章 比賽

簡介目錄
Product Code: MCP24302

Global Heart Attack Diagnostics Market to Reach US$19.8 Billion by 2030

The global market for Heart Attack Diagnostics estimated at US$13.7 Billion in the year 2023, is expected to reach US$19.8 Billion by 2030, growing at a CAGR of 5.5% over the analysis period 2023-2030. Hospitals End-Use, one of the segments analyzed in the report, is expected to record a 6.1% CAGR and reach US$9.8 Billion by the end of the analysis period. Growth in the Diagnostic Centers End-Use segment is estimated at 5.1% CAGR over the analysis period.

The U.S. Market is Estimated at US$3.7 Billion While China is Forecast to Grow at 9.0% CAGR

The Heart Attack Diagnostics market in the U.S. is estimated at US$3.7 Billion in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$4.2 Billion by the year 2030 trailing a CAGR of 9.0% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 2.2% and 5.6% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 3.4% CAGR.

Global Heart Attack Diagnostics Market - Key Trends and Drivers Summarized

Why Are Heart Attack Diagnostics a Game-Changer in Cardiovascular Care?

Heart attack diagnostics have become a cornerstone of modern cardiovascular care, offering critical tools for the early and precise detection of myocardial infarction (MI), which can significantly alter patient outcomes. But what exactly makes these diagnostics so impactful, and why is their role in healthcare becoming increasingly indispensable? Heart attacks occur when a blockage restricts blood flow to the heart, causing tissue damage that, if not treated promptly, can lead to irreversible damage or death. Timely diagnosis is crucial because the effectiveness of life-saving interventions like thrombolysis and percutaneous coronary intervention (PCI) hinges on early detection. The concept of the “golden hour”—the critical time window immediately following the onset of symptoms—makes it imperative that clinicians have access to reliable and rapid diagnostic tools to guide treatment decisions. Current diagnostic approaches rely on a combination of electrocardiograms (ECGs), cardiac biomarker testing, and imaging techniques to identify the presence and severity of heart damage. The speed and accuracy of these tools are key in determining whether a patient receives appropriate care in time, highlighting the need for continuous innovation in heart attack diagnostics. This ongoing evolution not only improves survival rates but also minimizes long-term complications, making these technologies vital for both emergency and routine clinical practice.

Which Emerging Trends Are Shaping the Heart Attack Diagnostics Market?

The heart attack diagnostics market is undergoing a transformative phase, driven by cutting-edge innovations and shifts in clinical practices aimed at improving patient outcomes. One of the most significant developments is the growing adoption of high-sensitivity cardiac troponin (hs-cTn) assays, which can detect extremely low levels of troponin, a key biomarker for myocardial injury. This enhanced sensitivity allows for earlier and more accurate detection of heart attacks, reducing time-to-treatment and improving prognostic accuracy, especially in patients with atypical symptoms. Another major trend is the proliferation of point-of-care testing (POCT) devices, which enable rapid diagnosis at the bedside or even in pre-hospital settings such as ambulances. These portable devices are transforming emergency care by providing results in minutes, thereby supporting quicker triage and reducing reliance on centralized laboratory testing. In addition, the integration of artificial intelligence (AI) and machine learning in diagnostic platforms is revolutionizing the interpretation of complex data, such as ECG patterns and imaging results, leading to earlier detection of subtle signs that might be overlooked by human clinicians. Moreover, multi-marker panels that combine several biomarkers—such as natriuretic peptides and inflammatory markers—are gaining attention, as they offer a more nuanced view of cardiac health and help differentiate heart attacks from other cardiac conditions. Collectively, these trends are making heart attack diagnostics faster, more accurate, and increasingly personalized, reflecting a shift towards precision medicine in cardiovascular care.

How Are New Technologies Redefining Heart Attack Diagnostics?

Technological breakthroughs are reshaping the heart attack diagnostics landscape, making tools more efficient, accessible, and accurate than ever before. One of the most impactful advancements is the miniaturization of diagnostic devices, which has led to the creation of portable and handheld systems that can deliver rapid test results at the patient’s side, even in remote or resource-limited settings. These devices, which include point-of-care cardiac biomarker analyzers and portable ECG monitors, are transforming emergency care by enabling immediate diagnosis and treatment decisions without the need for complex laboratory setups. Wearable technologies are another game-changer in this space, with smartwatches and health bands now equipped to monitor cardiac activity continuously, alerting users and healthcare providers to potential heart attack symptoms in real time. This capability is particularly valuable for high-risk patients, as it allows for proactive management and faster response to potential cardiac events. Additionally, artificial intelligence (AI) is enhancing the capabilities of diagnostic imaging, such as echocardiograms, CT scans, and MRIs, by enabling rapid and more precise interpretation of complex cardiac data. AI-driven platforms can detect subtle patterns and anomalies that might be missed by human eyes, leading to earlier and more confident diagnoses. Furthermore, cloud-based platforms and telehealth integration are enabling remote diagnostics, making it easier for clinicians to access and interpret test results from virtually anywhere. These technological innovations are not only improving the accuracy and accessibility of heart attack diagnostics but are also revolutionizing the way cardiovascular care is delivered, paving the way for a more proactive, data-driven approach to patient management.

What Are the Key Drivers Behind the Rapid Growth of the Heart Attack Diagnostics Market?

The growth in the heart attack diagnostics market is driven by a variety of factors, primarily fueled by advancements in technology, an increasing burden of cardiovascular diseases, and a shift towards rapid and accessible diagnostic solutions. One of the main growth drivers is the global rise in cardiovascular diseases, which remain the leading cause of death worldwide. The aging population, coupled with the increasing prevalence of lifestyle-related risk factors such as obesity, hypertension, and diabetes, is significantly expanding the patient pool in need of reliable diagnostic tools. Moreover, the heightened awareness of the importance of early detection and prevention is boosting demand for advanced biomarker assays and non-invasive imaging technologies that can identify heart attacks in their earliest stages. Another key driver is the growing adoption of point-of-care testing (POCT) devices, which provide rapid diagnostic capabilities in emergency settings, outpatient clinics, and even home care environments. These portable devices are meeting the need for quicker diagnosis and treatment initiation, reducing the strain on hospital laboratories and improving patient throughput in busy emergency departments. Technological innovations, such as AI-enhanced diagnostic platforms and high-sensitivity biomarker tests, are further propelling market growth by offering improved diagnostic accuracy and enabling personalized risk assessment. Additionally, the rising use of telehealth and remote monitoring solutions is expanding the reach of heart attack diagnostics, particularly in rural and underserved areas where access to traditional healthcare facilities is limited. Favorable regulatory frameworks and reimbursement policies are also encouraging the development and adoption of new diagnostic technologies, making them more accessible to a broader patient base. These factors, combined with ongoing investment in research and development, are driving the heart attack diagnostics market forward, establishing it as a key component in the evolving landscape of cardiovascular care.

Select Competitors (Total 35 Featured) -

  • Abbott Laboratories, Inc.
  • ACS Diagnostics
  • Baxter International, Inc.
  • Beckman Coulter, Inc.
  • Canon Medical Systems USA, Inc.
  • F. Hoffmann-La Roche AG
  • GE Healthcare
  • HeartBeam
  • Midmark Corporation
  • Philips Healthcare

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Heart Attack Diagnostics - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Prevalence of Cardiovascular Diseases Drives Demand for Heart Attack Diagnostic Solutions
    • Here's the Story: How Growing Awareness of Early Detection Expands the Addressable Market for Heart Attack Diagnostics
    • Increasing Adoption of Point-of-Care Testing Propels Market Growth for Rapid Diagnostic Tools
    • Advancements in Biomarker Identification Strengthen Business Case for High-Sensitivity Cardiac Tests
    • Here's How the Shift Towards Personalized Medicine Generates Opportunities for Advanced Cardiac Diagnostic Platforms
    • Rising Focus on Minimally Invasive Testing Boosts Market Potential for Non-Invasive Imaging Technologies
    • Expansion of Telemedicine and Remote Monitoring Transforms Market Dynamics for Heart Attack Diagnostics
    • Emphasis on Reducing Diagnosis Time in Emergency Settings Sustains Demand for Quick and Accurate Testing Methods
    • Here's How Growing Investments in AI and Machine Learning Drive Innovation in Predictive Cardiac Diagnostic Tools
    • Increasing Use of Wearable Health Devices Enhances Market Scope for Continuous Heart Health Monitoring
    • Emergence of At-Home Testing Kits Unlocks New Market Potential in Consumer-Driven Cardiac Health Management
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Heart Attack Diagnostics Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Heart Attack Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Heart Attack Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 4: World 16-Year Perspective for Heart Attack Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2024 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Hospitals End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Hospitals End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 7: World 16-Year Perspective for Hospitals End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Diagnostic Centers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Diagnostic Centers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 10: World 16-Year Perspective for Diagnostic Centers End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Ambulatory Surgery Centers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Ambulatory Surgery Centers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 13: World 16-Year Perspective for Ambulatory Surgery Centers End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 16: World 16-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Heart Attack Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 17: USA Recent Past, Current & Future Analysis for Heart Attack Diagnostics by End-Use - Hospitals End-Use, Diagnostic Centers End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 18: USA Historic Review for Heart Attack Diagnostics by End-Use - Hospitals End-Use, Diagnostic Centers End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 19: USA 16-Year Perspective for Heart Attack Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostic Centers End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • CANADA
    • TABLE 20: Canada Recent Past, Current & Future Analysis for Heart Attack Diagnostics by End-Use - Hospitals End-Use, Diagnostic Centers End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 21: Canada Historic Review for Heart Attack Diagnostics by End-Use - Hospitals End-Use, Diagnostic Centers End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 22: Canada 16-Year Perspective for Heart Attack Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostic Centers End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • JAPAN
    • Heart Attack Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 23: Japan Recent Past, Current & Future Analysis for Heart Attack Diagnostics by End-Use - Hospitals End-Use, Diagnostic Centers End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 24: Japan Historic Review for Heart Attack Diagnostics by End-Use - Hospitals End-Use, Diagnostic Centers End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 25: Japan 16-Year Perspective for Heart Attack Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostic Centers End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • CHINA
    • Heart Attack Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 26: China Recent Past, Current & Future Analysis for Heart Attack Diagnostics by End-Use - Hospitals End-Use, Diagnostic Centers End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 27: China Historic Review for Heart Attack Diagnostics by End-Use - Hospitals End-Use, Diagnostic Centers End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 28: China 16-Year Perspective for Heart Attack Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostic Centers End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • EUROPE
    • Heart Attack Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 29: Europe Recent Past, Current & Future Analysis for Heart Attack Diagnostics by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 30: Europe Historic Review for Heart Attack Diagnostics by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 31: Europe 16-Year Perspective for Heart Attack Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2024 & 2030
    • TABLE 32: Europe Recent Past, Current & Future Analysis for Heart Attack Diagnostics by End-Use - Hospitals End-Use, Diagnostic Centers End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 33: Europe Historic Review for Heart Attack Diagnostics by End-Use - Hospitals End-Use, Diagnostic Centers End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 34: Europe 16-Year Perspective for Heart Attack Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostic Centers End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • FRANCE
    • Heart Attack Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 35: France Recent Past, Current & Future Analysis for Heart Attack Diagnostics by End-Use - Hospitals End-Use, Diagnostic Centers End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 36: France Historic Review for Heart Attack Diagnostics by End-Use - Hospitals End-Use, Diagnostic Centers End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 37: France 16-Year Perspective for Heart Attack Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostic Centers End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • GERMANY
    • Heart Attack Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 38: Germany Recent Past, Current & Future Analysis for Heart Attack Diagnostics by End-Use - Hospitals End-Use, Diagnostic Centers End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 39: Germany Historic Review for Heart Attack Diagnostics by End-Use - Hospitals End-Use, Diagnostic Centers End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 40: Germany 16-Year Perspective for Heart Attack Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostic Centers End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • ITALY
    • TABLE 41: Italy Recent Past, Current & Future Analysis for Heart Attack Diagnostics by End-Use - Hospitals End-Use, Diagnostic Centers End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 42: Italy Historic Review for Heart Attack Diagnostics by End-Use - Hospitals End-Use, Diagnostic Centers End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 43: Italy 16-Year Perspective for Heart Attack Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostic Centers End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • UNITED KINGDOM
    • Heart Attack Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 44: UK Recent Past, Current & Future Analysis for Heart Attack Diagnostics by End-Use - Hospitals End-Use, Diagnostic Centers End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 45: UK Historic Review for Heart Attack Diagnostics by End-Use - Hospitals End-Use, Diagnostic Centers End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 46: UK 16-Year Perspective for Heart Attack Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostic Centers End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • SPAIN
    • TABLE 47: Spain Recent Past, Current & Future Analysis for Heart Attack Diagnostics by End-Use - Hospitals End-Use, Diagnostic Centers End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 48: Spain Historic Review for Heart Attack Diagnostics by End-Use - Hospitals End-Use, Diagnostic Centers End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 49: Spain 16-Year Perspective for Heart Attack Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostic Centers End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • RUSSIA
    • TABLE 50: Russia Recent Past, Current & Future Analysis for Heart Attack Diagnostics by End-Use - Hospitals End-Use, Diagnostic Centers End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 51: Russia Historic Review for Heart Attack Diagnostics by End-Use - Hospitals End-Use, Diagnostic Centers End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 52: Russia 16-Year Perspective for Heart Attack Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostic Centers End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • REST OF EUROPE
    • TABLE 53: Rest of Europe Recent Past, Current & Future Analysis for Heart Attack Diagnostics by End-Use - Hospitals End-Use, Diagnostic Centers End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 54: Rest of Europe Historic Review for Heart Attack Diagnostics by End-Use - Hospitals End-Use, Diagnostic Centers End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 55: Rest of Europe 16-Year Perspective for Heart Attack Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostic Centers End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • ASIA-PACIFIC
    • Heart Attack Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 56: Asia-Pacific Recent Past, Current & Future Analysis for Heart Attack Diagnostics by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 57: Asia-Pacific Historic Review for Heart Attack Diagnostics by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 58: Asia-Pacific 16-Year Perspective for Heart Attack Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2024 & 2030
    • TABLE 59: Asia-Pacific Recent Past, Current & Future Analysis for Heart Attack Diagnostics by End-Use - Hospitals End-Use, Diagnostic Centers End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 60: Asia-Pacific Historic Review for Heart Attack Diagnostics by End-Use - Hospitals End-Use, Diagnostic Centers End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 61: Asia-Pacific 16-Year Perspective for Heart Attack Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostic Centers End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • AUSTRALIA
    • Heart Attack Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2024 (E)
    • TABLE 62: Australia Recent Past, Current & Future Analysis for Heart Attack Diagnostics by End-Use - Hospitals End-Use, Diagnostic Centers End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 63: Australia Historic Review for Heart Attack Diagnostics by End-Use - Hospitals End-Use, Diagnostic Centers End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 64: Australia 16-Year Perspective for Heart Attack Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostic Centers End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • INDIA
    • Heart Attack Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2024 (E)
    • TABLE 65: India Recent Past, Current & Future Analysis for Heart Attack Diagnostics by End-Use - Hospitals End-Use, Diagnostic Centers End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 66: India Historic Review for Heart Attack Diagnostics by End-Use - Hospitals End-Use, Diagnostic Centers End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 67: India 16-Year Perspective for Heart Attack Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostic Centers End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • SOUTH KOREA
    • TABLE 68: South Korea Recent Past, Current & Future Analysis for Heart Attack Diagnostics by End-Use - Hospitals End-Use, Diagnostic Centers End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 69: South Korea Historic Review for Heart Attack Diagnostics by End-Use - Hospitals End-Use, Diagnostic Centers End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 70: South Korea 16-Year Perspective for Heart Attack Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostic Centers End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 71: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Heart Attack Diagnostics by End-Use - Hospitals End-Use, Diagnostic Centers End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 72: Rest of Asia-Pacific Historic Review for Heart Attack Diagnostics by End-Use - Hospitals End-Use, Diagnostic Centers End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 73: Rest of Asia-Pacific 16-Year Perspective for Heart Attack Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostic Centers End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • LATIN AMERICA
    • Heart Attack Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2024 (E)
    • TABLE 74: Latin America Recent Past, Current & Future Analysis for Heart Attack Diagnostics by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 75: Latin America Historic Review for Heart Attack Diagnostics by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 76: Latin America 16-Year Perspective for Heart Attack Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2024 & 2030
    • TABLE 77: Latin America Recent Past, Current & Future Analysis for Heart Attack Diagnostics by End-Use - Hospitals End-Use, Diagnostic Centers End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 78: Latin America Historic Review for Heart Attack Diagnostics by End-Use - Hospitals End-Use, Diagnostic Centers End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 79: Latin America 16-Year Perspective for Heart Attack Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostic Centers End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • ARGENTINA
    • TABLE 80: Argentina Recent Past, Current & Future Analysis for Heart Attack Diagnostics by End-Use - Hospitals End-Use, Diagnostic Centers End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 81: Argentina Historic Review for Heart Attack Diagnostics by End-Use - Hospitals End-Use, Diagnostic Centers End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 82: Argentina 16-Year Perspective for Heart Attack Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostic Centers End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • BRAZIL
    • TABLE 83: Brazil Recent Past, Current & Future Analysis for Heart Attack Diagnostics by End-Use - Hospitals End-Use, Diagnostic Centers End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 84: Brazil Historic Review for Heart Attack Diagnostics by End-Use - Hospitals End-Use, Diagnostic Centers End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 85: Brazil 16-Year Perspective for Heart Attack Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostic Centers End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • MEXICO
    • TABLE 86: Mexico Recent Past, Current & Future Analysis for Heart Attack Diagnostics by End-Use - Hospitals End-Use, Diagnostic Centers End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 87: Mexico Historic Review for Heart Attack Diagnostics by End-Use - Hospitals End-Use, Diagnostic Centers End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 88: Mexico 16-Year Perspective for Heart Attack Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostic Centers End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • REST OF LATIN AMERICA
    • TABLE 89: Rest of Latin America Recent Past, Current & Future Analysis for Heart Attack Diagnostics by End-Use - Hospitals End-Use, Diagnostic Centers End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 90: Rest of Latin America Historic Review for Heart Attack Diagnostics by End-Use - Hospitals End-Use, Diagnostic Centers End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 91: Rest of Latin America 16-Year Perspective for Heart Attack Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostic Centers End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • MIDDLE EAST
    • Heart Attack Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2024 (E)
    • TABLE 92: Middle East Recent Past, Current & Future Analysis for Heart Attack Diagnostics by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 93: Middle East Historic Review for Heart Attack Diagnostics by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 94: Middle East 16-Year Perspective for Heart Attack Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2024 & 2030
    • TABLE 95: Middle East Recent Past, Current & Future Analysis for Heart Attack Diagnostics by End-Use - Hospitals End-Use, Diagnostic Centers End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 96: Middle East Historic Review for Heart Attack Diagnostics by End-Use - Hospitals End-Use, Diagnostic Centers End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 97: Middle East 16-Year Perspective for Heart Attack Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostic Centers End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • IRAN
    • TABLE 98: Iran Recent Past, Current & Future Analysis for Heart Attack Diagnostics by End-Use - Hospitals End-Use, Diagnostic Centers End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 99: Iran Historic Review for Heart Attack Diagnostics by End-Use - Hospitals End-Use, Diagnostic Centers End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 100: Iran 16-Year Perspective for Heart Attack Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostic Centers End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • ISRAEL
    • TABLE 101: Israel Recent Past, Current & Future Analysis for Heart Attack Diagnostics by End-Use - Hospitals End-Use, Diagnostic Centers End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 102: Israel Historic Review for Heart Attack Diagnostics by End-Use - Hospitals End-Use, Diagnostic Centers End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 103: Israel 16-Year Perspective for Heart Attack Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostic Centers End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • SAUDI ARABIA
    • TABLE 104: Saudi Arabia Recent Past, Current & Future Analysis for Heart Attack Diagnostics by End-Use - Hospitals End-Use, Diagnostic Centers End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 105: Saudi Arabia Historic Review for Heart Attack Diagnostics by End-Use - Hospitals End-Use, Diagnostic Centers End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 106: Saudi Arabia 16-Year Perspective for Heart Attack Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostic Centers End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 107: UAE Recent Past, Current & Future Analysis for Heart Attack Diagnostics by End-Use - Hospitals End-Use, Diagnostic Centers End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 108: UAE Historic Review for Heart Attack Diagnostics by End-Use - Hospitals End-Use, Diagnostic Centers End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 109: UAE 16-Year Perspective for Heart Attack Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostic Centers End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • REST OF MIDDLE EAST
    • TABLE 110: Rest of Middle East Recent Past, Current & Future Analysis for Heart Attack Diagnostics by End-Use - Hospitals End-Use, Diagnostic Centers End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 111: Rest of Middle East Historic Review for Heart Attack Diagnostics by End-Use - Hospitals End-Use, Diagnostic Centers End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 112: Rest of Middle East 16-Year Perspective for Heart Attack Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostic Centers End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • AFRICA
    • Heart Attack Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2024 (E)
    • TABLE 113: Africa Recent Past, Current & Future Analysis for Heart Attack Diagnostics by End-Use - Hospitals End-Use, Diagnostic Centers End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 114: Africa Historic Review for Heart Attack Diagnostics by End-Use - Hospitals End-Use, Diagnostic Centers End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 115: Africa 16-Year Perspective for Heart Attack Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostic Centers End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2024 & 2030

IV. COMPETITION